Last update:

Oncology news

A single enzyme keeps neuroblastoma alive—how to shut it off

The tumor begins before birth. Somewhere in the developing fetus, neural crest cells that should have matured into adrenal tissue or sympathetic ganglia take a wrong turn, and a child is born harboring a malignancy that may ...

Second primary invasive melanoma rate in Queensland reaches plateau after decades-long rise

A study among more than 100,000 Queensland residents has revealed that while the incidence of developing second primary invasive cutaneous melanomas increased from the 1980s through the early 2000s, the rising trend has now ...

Scientists target key protein duo driving colon, liver cancer

Cedars-Sinai Health Sciences University investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver cancer. Findings from the preclinical ...

How pancreatic tumors thwart an iron-driven demise

Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be harnessed for cancer therapy. Given that more than 95% of pancreatic ductal adenocarcinomas (PDACs) harbor ...